Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival
- 1 December 1993
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 105 (6) , 1846-1856
- https://doi.org/10.1016/0016-5085(93)91084-u
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Transforming growth factor-beta: recent progress and new challenges.The Journal of cell biology, 1992
- Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha.Journal of Clinical Investigation, 1992
- Transforming growth factor beta1 in ductal carcinoma in situ and invasive carcinomas of the breastEuropean Journal Of Cancer, 1992
- Pattern of Growth Factor, Proto-Oncogene and Carcinoembryonic Antigen Gene Expression in Human Colorectal Carcinoma Cell LinesOncology, 1992
- A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancerCancer, 1991
- Loss of growth inhibitory activity of TGF-β toward normal human mammary epithelial cells grown within collagen gel matrixBiochemical and Biophysical Research Communications, 1990
- The Transforming Growth Factor-beta FamilyAnnual Review of Cell Biology, 1990
- Immunocytochemically Detectable TGF-β Associated with Malignancy in Thyroid Epithelial NeoplasiaGrowth Factors, 1990
- Stimulatory Effects of Transforming Growth Factor-beta and Epidermal Growth Factor on Epidermal Cell Outgrowth from Porcine Skin Explant CulturesJournal of Investigative Dermatology, 1988
- β-Transforming Growth Factor is stored in human blood platelets as a latent high molecular weight complexBiochemical and Biophysical Research Communications, 1986